| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 74.06B | 68.53B | 57.39B | 56.07B | 58.14B | 50.22B |
| Gross Profit | 65.25B | 62.44B | 55.38B | 53.53B | 55.67B | 38.56B |
| EBITDA | 12.20B | 15.06B | 10.95B | 9.52B | 12.01B | -3.81B |
| Net Income | 8.48B | 7.45B | 5.25B | 4.49B | 6.75B | -4.66B |
Balance Sheet | ||||||
| Total Assets | 6.76T | 6.65T | 6.76T | 6.61T | 7.14T | 6.79T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 1.24T | 1.80T | 1.99T | 2.80T | 2.34T |
| Total Debt | 221.96B | 222.05B | 198.94B | 182.47B | 690.05B | 426.81B |
| Total Liabilities | 6.56T | 6.46T | 6.55T | 6.42T | 6.94T | 6.60T |
| Stockholders Equity | 204.69B | 197.23B | 206.18B | 191.01B | 192.74B | 191.39B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 24.24B | 1.75B | -768.00B | 0.00 | 852.74B |
| Operating Cash Flow | 0.00 | 27.62B | 6.71B | -759.85B | 0.00 | 856.01B |
| Investing Cash Flow | 0.00 | -350.27B | -302.83B | -49.66B | -44.37B | -133.56B |
| Financing Cash Flow | 0.00 | -143.11B | -1.73B | -1.90B | 81.65B | -1.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥149.05B | 8.04 | 3.68% | 2.26% | 9.34% | 20.61% | |
72 Outperform | ¥162.51B | 8.80 | ― | 2.63% | 23.55% | -21.15% | |
72 Outperform | ¥159.12B | 7.55 | ― | 2.29% | 13.93% | 54.44% | |
71 Outperform | ¥157.42B | 7.21 | ― | 2.96% | 14.85% | 21.17% | |
69 Neutral | ¥163.08B | 9.79 | ― | 2.56% | 17.66% | 49.06% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | ¥170.39B | 9.13 | ― | 2.23% | 29.06% | 40.95% |